Target intelligence / Profile preview

Ribosome maturation protein SBDS (SBDS)

Target
SBDS
Molecular classification
Other (ribosome assembly/biogenesis factor), Ribosome biogenesis factor
01

Overview

Ribosome maturation protein SBDS is a highly conserved protein encoded by the *SBDS* gene, primarily involved in the late cytoplasmic maturation of the 60S large ribosomal subunit. It acts with the GTPase EFL1 to catalyze the removal of the anti-association factor eIF6 from nascent 60S subunits, enabling 80S ribosome assembly and active translation[1][2][3][4][5]. SBDS is essential for ribosome biogenesis, RNA metabolism, and maintaining proper protein synthesis. It is also implicated in cell division, cell movement, and cellular responses to stress, although these roles are less well-defined[1][4][5]. Mutations in SBDS cause Shwachman-Diamond syndrome, an autosomal recessive disorder characterized by bone marrow failure, pancreatic insufficiency, skeletal abnormalities, and an increased risk of acute myeloid leukemia and myelodysplastic syndromes[4][5]. There are currently no drugs that directly target SBDS, and the molecule functions as a ribosome biogenesis factor rather than a classic drug target such as a receptor or enzyme.

Other names
CGI-97SDO1SDSSWDSShwachman-Bodian-Diamond syndrome proteinFLJ10917ribosome assembly guanine nucleotide exchange factor
02

Biological functions

Ribosome assembly/biogenesisRNA metabolismProtein synthesisCell proliferationCell divisionStress responseApoptosis regulation
03

Disease associations

Bone marrow failure (Shwachman-Diamond syndrome)Cancer (mainly hematological—acute myeloid leukemia, myelodysplastic syndrome)Hematological dysfunctionSkeletal abnormalitiesPancreatic insufficiency
04

Safety considerations

Loss-of-function mutations cause multisystem disease (Shwachman-Diamond syndrome) with increased risk of blood cancers, bone marrow failure, and pancreatic insufficiency
05

Biomarkers

Mutations in SBDS gene (for diagnosis and risk stratification in Shwachman-Diamond syndrome and predisposition to hematological malignancies)

Beyond the preview

Go deeper on Ribosome maturation protein SBDS (SBDS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosome maturation protein SBDS (SBDS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call